Cellebrite Shares Jump After Strong Q1 and Renewed Analyst Backing
Cellebrite DI's stock climbed about 5.8% in morning trade to $15.58 after the company posted Q1 2026 results that topped expectations on both earnings and revenue. Robust ARR growth, sequential net new ARR stabilization, and early traction for new AI and forensics products, together with fresh and reiterated Buy ratings from several firms, have dri…